newsfilter
← Latest News
GlobeNewswire·

Wesana Health Commits Funding of $1.5 Million To Support MAPS' Research Pipeline

MAPS to Investigate Viability of Research Pathway for MDMA-Assisted Therapy to Treat Traumatic Brain Injury Effort Positions MAPS, Sponsor of the Only Completed Phase 3 Trial for Psychedelic-Assisted Therapy, to Serve New Unique Role Within